TriSalus Life Sciences, Inc. (TLSI) Debt Components
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD $33.06M; Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD (m); Notes Payable, Related PartiesUSD (m).
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD $33.08M; Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD (m); Notes Payable, Related PartiesUSD (m).
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD $33.05M; Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD (m); Notes Payable, Related PartiesUSD (m).
- 2025-09-30: Long-term Debt, Excluding Current MaturitiesUSD $32.76M; Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD (m); Notes Payable, Related PartiesUSD (m).
TriSalus Life Sciences, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Notes Payable, Current USD | Debt Instrument, Face Amount USD | Notes Payable, Related Parties USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|
| 2026-06-30 | $33.06M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $33.08M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $33.05M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $32.76M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $32.27M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $31.70M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $22.08M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $21.68M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $21.29M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.57M | $1.50M | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | $1.36M |
| 2022-12-31 | (m) | $944.00K | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $1.50M | (m) | $944.00K |
| 2022-12-31 | (m) | (m) | (m) | $39.07K | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | $944.00K |
| 2022-06-30 | (m) | (m) | (m) | $544.00K | $944.00K |
| 2022-05-24 | (m) | (m) | $1.50M | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | $544.00K | $809.00K |
| 2021-12-31 | (m) | (m) | (m) | $0.00 | $544.00K |
| 2020-12-31 | (m) | (m) | (m) | $0.00 | (m) |
| 2020-12-22 | (m) | (m) | (m) | $178.08K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |